GPGI, Inc. GPGI

GPGI Inc is a diversified holding permanent capital platform designed to acquire, own, and scale high-quality businesses that hold great positions in good industries.

• Zacks Investment Research 16 sept

  Zacks Industry Outlook Grupo Cibest, POSCO, Griffon and GPGI

  The Zacks Diversified Operations industry is experiencing solid momentum driven by manufacturing sector strength, robust aerospace and defense markets, and commercial aviation growth. However, supply-chain disruptions remain a concern. The industry ranks #59 among 247 Zacks industries but has underperformed the S&P 500 by 28.2% over the past year. Four stocks are highlighted as leaders: Grupo Cibest, POSCO Holdings, Griffon Corp, and GPGI Inc.

  

• GlobeNewswire Inc. 8 sept

  INVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in Regeneron Pharmaceuticals, Inc. of Class Action Lawsuit and Upcoming Deadlines – REGN

  Pomerantz Law Firm has filed class action lawsuits against Regeneron Pharmaceuticals, Capricor Therapeutics, and GPGI, Inc. for alleged securities fraud. The primary focus is on Regeneron, where a Phase III clinical trial for Fianlimab-Libtayo failed to meet its primary endpoint, causing the stock to decline significantly on two separate occasions in April and May 2026. Investors with losses are urged to contact the firm by September 14, 2026, to potentially become lead plaintiffs.

  

• GlobeNewswire Inc. 8 sept

  INVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in GPGI, Inc. of Class Action Lawsuit and Upcoming Deadlines – GPGI

  A class action lawsuit has been filed against GPGI, Inc. for alleged securities fraud following significant stock price declines. The company's Husky Technologies segment showed deteriorating financial performance with compressed margins and declining EBITDA, leading to substantial guidance cuts in May 2026. Investors have until September 14, 2026, to request Lead Plaintiff status.

  

• GlobeNewswire Inc. 7 sept

  Bronstein, Gewirtz & Grossman LLC Urges GPGI, Inc. Investors to Act: Class Action Filed Alleging Investor Harm

  A class action lawsuit has been filed against GPGI, Inc. (formerly CompoSecure, Inc.) alleging that company defendants made false and misleading statements regarding the Husky acquisition. The complaint claims defendants overstated Husky's value, misrepresented revenue and EBITDA targets, and prioritized generating fees for Resolute Holdings over shareholder value. Investors who purchased GPGI Class A common stock between November 3, 2025 and May 6, 2026 are encouraged to join the case, with a lead plaintiff deadline of September 14, 2026.

  

• GlobeNewswire Inc. 3 sept

  GPGI, Inc. Investors Have Until September 14th to Seek Lead Plaintiff Role with Bragar Eagel & Squire, P.C.

  A class action lawsuit has been filed against GPGI, Inc. in the U.S. District Court for the Southern District of New York on behalf of investors who purchased GPGI Class A common stock between November 3, 2025 and May 6, 2026. The lawsuit alleges that defendants made materially false and misleading statements regarding the Husky acquisition, including overstating its value, misrepresenting revenue and EBITDA targets, and prioritizing fee generation over shareholder value creation. Investors have until September 14, 2026 to apply for lead plaintiff status.